1.385USD-2.81%Mkt Cap: 169.94M USDP/E: —Last update: 2026-06-01
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a pr…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap169.94M USD
Enterprise Value-19.35M USD
Revenue (TTM)1.55M USD
Gross Profit1.55M USD
Net Income (TTM)-63.06M USD
Revenue/Share0.0180 USD
Last Price1.385 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees38
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.36
PEG—
EV/EBITDA0.31
EV/Revenue-12.52
P/S114.35
P/B4.16
EPS (TTM)-0.64
EPS (Forward)-1.04
52W Range
1.00019% of range3.060
52W High3.060 USD
52W Low1.000 USD
Profitability
Gross Margin100.00%
Oper. Margin-1116.23%
EBITDA Margin0.00%
Profit Margin-4078.78%
ROE-150.97%
ROA-55.53%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-49.04M USD
CapEx (TTM)302.00K USD
FCF Margin-1869.55%
FCF Yield-17.01%
Net Debt-47.58M USD
Net Debt/EBITDA0.77
Balance Sheet
Debt/Equity1.40
Current Ratio8.01
Quick Ratio7.83
Book Value/Sh0.3410 USD
Cash/Share6.456 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)6.333 USD
Target Range2.000 USD – 8.000 USD
# Analysts6
Ownership
Shares Out.124.50M
Float14.07M
Insiders2.48%
Institutions24.99%
Short Interest
Short Ratio3.1d
Short % Float6.58%
Short % Out.6.53%
Shares Short7.81M
Short (prev mo.)8.45M
Technical
SMA 501.671 (-17.1%)
SMA 2001.896 (-27.0%)
Beta1.04
S&P 52W Chg27.94%
Avg Vol (30d)1.34M
Avg Vol (10d)1.60M
Technical Indicators
RSI (14)35.7
MACD-0.1067
MACD Signal-0.0796
MACD Hist.-0.0271
BB Upper2.097 USD
BB Middle1.655 USD
BB Lower1.214 USD
BB Width53.33%
ATR (14)0.1099 USD
Vol Ratio (20d)0.25x